Winslow, Evans & Crocker, Inc. - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 272 filers reported holding BLUEBIRD BIO INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Winslow, Evans & Crocker, Inc. ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2020$133,000
+11.8%
3,055
+38.9%
0.02%
-13.8%
Q3 2020$119,000
-27.9%
2,200
-18.5%
0.03%
-34.1%
Q2 2020$165,000
+31.0%
2,7000.0%0.04%
+7.3%
Q1 2020$126,000
-66.8%
2,700
-37.2%
0.04%
-57.7%
Q4 2019$380,000
-1.6%
4,300
+2.4%
0.10%
-10.2%
Q3 2019$386,000
-28.0%
4,2000.0%0.11%
-27.5%
Q2 2019$536,000
-14.9%
4,200
+5.0%
0.15%
-16.8%
Q1 2019$630,000
+58.3%
4,0000.0%0.18%
+33.6%
Q4 2018$398,000
-28.4%
4,000
+5.3%
0.13%
-20.7%
Q3 2018$556,000
-1.8%
3,800
+5.6%
0.17%
-4.5%
Q2 2018$566,000
-99.9%
3,600
+5.9%
0.18%
-5.9%
Q1 2018$580,550,000
+117.3%
3,400
+126.7%
0.19%
+118.6%
Q4 2017$267,150,000
-48.8%
1,500
-60.5%
0.09%
-50.3%
Q3 2017$521,930,000
+71.3%
3,800
+31.0%
0.17%
+106.0%
Q2 2017$304,645,000
+15.6%
2,9000.0%0.08%
+1.2%
Q1 2017$263,610,000
+33.5%
2,900
-9.4%
0.08%
+36.1%
Q4 2016$197,440,000
-46.1%
3,200
-22.2%
0.06%
+17.3%
Q3 2016$366,012,000
+745.5%
4,114
+311.4%
0.05%
+300.0%
Q2 2016$43,290,000
+1.9%
1,0000.0%0.01%0.0%
Q1 2016$42,500,000
-33.8%
1,0000.0%0.01%
-27.8%
Q4 2015$64,220,000
-24.9%
1,0000.0%0.02%
-33.3%
Q3 2015$85,550,0001,0000.03%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,550,000$7,518,0001.50%
Birchview Capital, LP 84,000$407,0000.29%
PDT Partners, LLC 519,485$2,520,0000.22%
OCCUDO QUANTITATIVE STRATEGIES LP 320,922$1,556,0000.13%
Virtus ETF Advisers LLC 40,607$197,0000.09%
Baker Brothers Advisors 2,499,715$12,124,0000.07%
Green Alpha Advisors, LLC 14,660$71,0000.05%
Quinn Opportunity Partners LLC 140,824$683,0000.03%
Rafferty Asset Management, LLC 979,122$4,749,0000.03%
Inspire Investing, LLC 48,724$236,0000.03%
View complete list of BLUEBIRD BIO INC shareholders